Intellia Therapeutics (NTLA) EBIT Margin Growth (5y) (2020 - 2026)
Intellia Therapeutics (NTLA) EBIT Margin Growth (5y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Intellia Therapeutics |
1.44 Bn |
1.44 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
5,225.00 |
| Dec 31, 2025 |
21,404.00 |
| Sep 30, 2025 |
-68,239.00 |
| Jun 30, 2025 |
-56,905.00 |
| Mar 31, 2025 |
-6,561.00 |
| Dec 31, 2024 |
-78,764.00 |
| Sep 30, 2024 |
-135,038.00 |
| Jun 30, 2024 |
-175,162.00 |
| Mar 31, 2024 |
-16,579.00 |
| Dec 31, 2023 |
756,072.00 |
| Sep 30, 2023 |
-76,798.00 |
| Jun 30, 2023 |
-66,613.00 |
| Mar 31, 2023 |
-58,782.00 |
| Dec 31, 2022 |
-44,042.00 |
| Sep 30, 2022 |
-57,853.00 |
| Jun 30, 2022 |
-42,995.00 |
| Mar 31, 2022 |
-107,362.00 |
| Dec 31, 2021 |
-43,328.00 |
| Sep 30, 2021 |
-2.38 Mn |
| Jun 30, 2021 |
-88,855.00 |
